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Abstract: This review identifies the ways in which tethered bilayer lipid membranes (tBLMs) can
be used for the identification of the actions of antimicrobials against lipid bilayers. Much of the
new research in this area has originated, or included researchers from, the southern hemisphere,
Australia and New Zealand in particular. More and more, tBLMs are replacing liposome release
assays, black lipid membranes and patch-clamp electrophysiological techniques because they use
fewer reagents, are able to obtain results far more quickly and can provide a uniformity of responses
with fewer artefacts. In this work, we describe how tBLM technology can and has been used to
identify the actions of numerous antimicrobial agents.
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1. Introduction
Antimicrobial peptides (AMPs) are of increasing interest as potential lead candidates for treating
infection because they are thought to be more impervious to antibacterial resistance mechanisms [1].
One of the most rapid and increasingly effective methods for testing the actions of antimicrobials that
target microbial membranes is to use tethered bilayer lipid membranes (tBLMs) in association with
electrical impedance spectroscopy (EIS). In this review, we outline the advantages of this technique
compared to other lipid membrane techniques and describe how tBLMs, in conjunction with EIS,
have been used to rapidly and reliably identify the actions of many AMPs.
The desire to study membranes and determine changes in their physical and electrical properties
encouraged the development of artificial lipid bilayer systems. The first of these was developed by
Mueller et al. [2] and was subsequently named black lipid membranes. These model membranes
consisted of a painted phospholipid bilayer across a small aperture, usually 1 mm in diameter,
between two chambers that held aqueous solutions. This system provided a planar lipid bilayer
that could be probed with electrical or basic optical techniques. The name black lipid membrane was
derived from the optical technique used to determine when the bilayer had formed. Once the film
had been painted on, the mixture would begin to thin and become a single spanning bilayer, this
would then cause interference of reflected light and render the membrane opaque [3]. The fact that
no underlying support existed meant that the membrane-associated proteins were able to function
without interference. However, non-polar solvents are required in the manufacture of these membranes
which alter the integral properties of the lipid bilayer [4].
Attempts to find alternatives, which abolished the solvent artefact in the membrane, led to the
production of phospholipid bilayers supported by solid substrates. Tamm and McConnell (1985)
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were the first to describe this technique, which enabled them to create extremely stable bilayers
supported by a number of different substrates (silicon oxide wafers, glass coverslips and quartz
slides). The ability to adhere to these surfaces was believed to originate from the silicious materials,
which have deprotonated free silanols at the surface at neutral pH [5]. Even though they had been
using zwitterionic phospholipids, an apparent interfacial potential was established allowing the
surface of the bilayer to be attracted to the surface of the substrate. However, as acknowledged by
Tamm and McConnell themselves, the fact that the substrate was adjacent to the bilayer meant that
a very thin water layer existed between the phospholipid and the solid support [5]. This meant that
the incorporation of transmembrane proteins was hampered by the high probability of the protein
interacting with the substrate surface [6,7]. This could cause both immobilization of the protein with
inhibition of function or cause denaturation of the protein in the vicinity of the contact point between
protein and substrate [8]. This has particularly been noted in the inability of integral proteins to diffuse
freely through solid-supported bilayer systems [9–12]. Not only is the inclusion of integral membrane
proteins difficult in solid-supported bilayer systems, but the study of the electrical properties of
these membranes is difficult to perform when the aqueous reservoir between the membrane and
substrate is so small [13]. Thus, a supported lipid bilayer with an appropriate reservoir space to allow
accommodation of transmembrane proteins and a free diffusion of ions was pursued.
Attempts at constructing novel solid-supported membranes that contained a larger reservoir
were made by laying phospholipid bilayers onto water swellable polymer cushions sitting between
the solid substrate and bilayer [7,14–16]. The silicious materials used in these studies enabled the
construction of polymer cushions that adhered directly to either the surface itself or a functionalized
surface, through silinisation, using either acrylamide, dextran or agarose substrates. Silinisation
could be used on metal solid substrates which could be incorporated into impedance spectroscopy
systems to determine the electrical properties of the membrane [17]. Further modification of the
polymer cushion substrates themselves allowed adherence to substrates, such as gold, through sulphur
coordination [18].
It was noted that applying a phospholipid bilayer onto a polymer cushion did not mitigate
inherent problems associated with membrane stability [19]. The issue of stability was circumvented
with a new functionalized polymer cushion that created anchor points for customized lipids to attach
and, in turn, tether the membrane to the cushion through hydrophobic forces [19]. This improvement
in stability did not abrogate the continuing issue of a reservoir that restricted ion diffusion between the
solid substrate and the phospholipid bilayer. A new membrane technology from Australia was reported
by Cornell et al., (1997), consisting of a membrane separated from the surface of the substrate through
the use of double-length reservoir half-membrane spanning diphytanyl (DLP) ethylene glycol tethers.
This enabled the formation of a lipid bilayer around the end of the DLP through the half-membrane
spanning component of the DLP chain [20]. The other end of the DLP was firmly attached to a gold
substrate surface through sulphur–gold coordination chemistry. This system took the concept of
tethering or anchoring the membrane to the solid substrate surface described by Beyer et al., (1996) and
removed the polymer cushion, thus creating a much larger reservoir space for transmembrane protein
insertion and free ion diffusion (Figure 1). This optimized reservoir space was enhanced by mixing
in polar spacer molecules, which prevented the formation of a monolayer beneath the membrane by
providing lateral separation of the tethers [13]. This system provides an enormous amount of flexibility
in the composition of the phospholipid bilayer, as any mixture of phospholipids able to create a bilayer
could be studied. Since then, several studies have investigated and described alternative tethering
components [21–30] and substrates such as liquid mercury [31,32] to create stable supported bilayers.
Southern hemisphere researchers of note in the development of new tethered bilayer architectures
are researchers from the McGuillivray group at the University of Aukland, and the Köper group at
Flinders University, in South Australia.
The variety of novel approaches to the design of tethering systems to maintain stable and dynamic
bilayer systems provides a large toolkit to create explicit solutions for particular biological problems
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such as identifying how antimicrobials interact with lipid bilayers. This review does not seek to
identify all the research into AMPs using tBLMs, rather, it seeks to detail what tBLM technology can
do to identify the actions of AMPs.
Figure 1. A basic tethered bilayer lipid membrane architecture. The use of membrane-tethering
molecules and spacer molecules creates a reservoir between the membrane and the substrate to provide
space for the transport of ions and the insertion of extended membrane-bound peptides or proteins.
2. Models of AMP–Lipid Membrane Interactions
In studying the interactions between lipid bilayers and antimicrobial peptides, a variety of models
have been proposed to identify the exact mechanism of action associated with these interactions.
Each family of peptides appears to interact with lipid bilayers in a unique manner and most
current interactions have been identified as either pore forming, intrinsic pore modulating or having
surfactant-like properties that induce membrane rupture or lysis [33–43]. Individual types of peptides
may not conform to a particular mode of action or have the qualities of each model, with some
peptides not fitting within any of these models [35,44–46]. The proposed mechanisms of action of
AMPs are briefly summarized here, along with a subsequent explanation of how tBLMs can be used
in conjunction with swept frequency electrical impedance spectroscopy (EIS) to distinguish between
these mechanisms.
2.1. Barrel-Stave Model
This model describes the formation of an ionic conductive pore through the membrane resembling
a barrel with individual peptides forming the staves. [33,47,48]. The process of pore formation involves
the insertion of peptides through the lipid bilayer, along with a successive aggregation to form a
transmembrane channel (Figure 2). An amphipathic peptide structure is required, in which the
hydrophobic regions are aligned with the hydrophobic inner domain of the lipid bilayer and the
hydrophilic regions face the pore lumen. This creates a hydrophilic channel through the lipid bilayer
allowing the free passage of ions and solutes through the membrane [47,48]. The diameter of the pore
lumen is intrinsically linked to the number peptides recruited, with larger groupings of peptides forming
larger pores, resulting in increased leakage of cell contents and potentially leading to cell death [35].
Figure 2. Schematic of how individual peptides might form the barrel-stave pore configuration in a
cell membrane.
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2.2. Interdigitated Peptide Toroidal Pore Model
The barrel-stave model has evolved into different forms, with a number of antimicrobial
peptides not conforming to the rudimentary barrel-stave model, namely magainins, protegrins and
melittin [48–52]. An alternate method was put forth by Matsuzaki et al. [49]. The toroidal model differs
from the barrel-stave model in that the lipid headgroups of the bilayer participate in the formation
of the pore. The structure of this pore demands that the inner and outer leaflets bend in such a way
as to form a pore composed of interdigitated peptide and phospholipid headgroups (See Figure 3).
In contrast to the barrel-stave model, the peptides remain associated with the headgroups of the lipids
and do not permeate through the hydrophobic chain regions [33].
Figure 3. The toroidal pore model has the antimicrobial peptides (AMPs) interdigitated between lipid
head groups as part of a pore within the membrane.
2.3. Carpet Model
This model describes the gathering of peptides at the lipid–water interface of the lipid bilayer,
attracted there through electrostatic forces. It was first theorized to describe the interactions of the
peptide dermaseptin [53]. This model has also been used to describe the interactions of peptides
such as ovispirin and melittin [33,54,55]. As the concentration of peptides increases at the lipid–water
interface, they form a ‘carpet’ across the surface of the bilayer (Figure 4). The peptides are reported
to permeabilize the membrane by disrupting phospholipid packing and are suggested to have
surfactant-like qualities in high concentrations, leading to the removal of small segments of the
bilayer through micellization [40].
Figure 4. The carpet model of cell membrane disruption has the accumulation of amphipathic AMPs as
a ‘carpet’ across the membrane, eventually promoting to the micellization of individual lipids creating
membrane defects.
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2.4. Intrinsic Pore Modulation Model by Changing the Critical Packing Paremeter (CPP)
A more recent model of peptide–lipid interactions, suggested by Australian researchers amongst
others, describes the process in terms of altering the critical packing parameter (CPP) of the bilayer
and, thereby, altering the size of membrane pores already present in the membrane [36,37,56–60].
The CPP concept was first introduced by Jacob Israelachvili during his time at Australian National
University [61,62]. This model aims to predict the morphology of lipids based on the ratio of the
lipid head groups’ surface area (a0) and the hydrophobic lipid chain lengths (l) with the overall
volume of the individual lipids (v), such that CPP = v/a0l. Within a planar bilayer, the overall CPP
= 1. An overall CCP = 1/3 describes a micelle but also describes the CPP of the lipids that make
up the curved regions of a toroidal pore (Figure 5) [36]. The CPP-pore modulation model suggests
the interaction of peptides is influencing the size of pre-existing pores or defects found within the
lipid bilayer [36]. Upon interacting with the lipid bilayer, the peptides disrupt the packing of the
surrounding lipids causing changes in the overall CPP of the bilayer. This interaction of lipids and
peptides can cause a change in the effective head group surface area (a0) compared to the lipid chain
length (l), either increasing or decreasing the CPP depending on the geometry of the peptide in the
bilayer. When the CPP of an individual lipid drops below unity within a lipid bilayer, it lacks sufficient
laxity for lateral movement beyond the existing boundaries. This model suggests that the need for
space may be resolved through movement of lipids into or out of existing toroidal pores where the
CPP = 1/3, and/or with an alteration in chain length to compensate for the change in the surface area
in the planar bilayer sections where the CPP has to remain equal to one.
Figure 5. The Critical Packing Parameter (CPP) model of toroidal pore modulation by antimicrobial
agents. This model predicts that the shape of peptides influences the lipid packing arrangement leading
to either an increase in intrinsic membrane pore radius and an overall slight thinning of the membrane,
as more lipids diffuse into pore regions, or a decrease in the intrinsic membrane pore radius with a
thickening of the membrane as more lipids diffuse out of the pore regions.
2.5. Identifying Mechanisms of Membrane Interaction Using EIS Techniques
Swept frequency electrical impedance spectroscopy is the method most commonly used to
identify the ionic conduction across a tethered bilayer lipid membrane. It also characterizes the
membrane capacitance, which identifies changes in membrane thickness and/or water content. These
changes in membrane thickness and/or water content are derived from the geometric properties of
a capacitor. In its simplest form, a lipid bilayer can be modelled as a parallel-plate capacitor, itself
in parallel with a resistor. The membrane thickness pertains to the distance between the two plates
of the capacitor and the water content determines the relative permittivity (εr). Thus, as membrane
capacitance increases, the membrane thickness (distance between the plates) decreases and/or the
water content (relative permittivity between the plates) increases. The opposite is true when the
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membrane capacitance decreases. When studying the interactions of antimicrobial peptides with lipid
bilayers, the ability to identify changes in either or both of these values can assist in isolating the
mechanisms of antimicrobial interactions.
A large increase in membrane conduction, with limited or only a small change in membrane
capacitance, indicates the formation of ion channels within the membrane, particularly if the
conduction effect does not readily disappear with subsequent wash steps. This type of response
is typical of pore forming AMPs where it would be expected that insertion and aggregation of the
peptides in the membrane would disrupt the packing of adjacent lipids, with a reduced influence on
packing structure at further distances from the annular ring [63]. A classic example of this would be
channels formed by the antibiotic α-hemolysin (Figure 6A,B) [64]. We can see a significant increase
in conduction across the membrane with an associated small increase in membrane capacitance
(Figure 6A). The small membrane capacitance change in this case can be attributed to the localized
disruption of phospholipid packing in the annular ring around the α-hemolysin as determined by
neutron reflectometry [65].
A large increase in membrane conduction that is also associated with a large increase in membrane
capacitance is suggestive of antimicrobials having a lytic or surfactant-like effect. It is expected that
these effects would be concentration dependent and that reaching a particular concentration threshold
would enable sequestration of lipids from the bilayer through micellization. These effects are typically
irreversible with subsequent wash steps and often washing will compound the effects. The increase in
membrane capacitance in this case is suggestive of the membrane getting thinner, probably due to the
removal of lipids from the bilayer as a result of the surfactant-like activity of the AMPs. An example of
this response is the human cathelicidin AMP LL-37 [66,67] (Figure 6C,D). The initial interaction of this
peptide can be described by the “carpet model”, with disruption of the membrane due to intercalation
of the peptide with lipid headgroups [68,69] and an associated decrease in membrane capacitance.
However, as has been noted [70], peptides that follow the “carpet model” can possess a threshold
concentration at which significant disruption of the phospholipid bilayer is observed. This would then
manifest itself as a large increase in bilayer capacitance as the surfactant-like effect of removing lipids
thins the bilayer.
In many cases, AMPs can be added that are known to be too small to traverse the membrane yet
can still induce increases or decreases in overall membrane conduction. In these sorts of responses,
there are typically only very small changes in membrane capacitance, if any. Typically, to some degree,
these AMPs can be readily washed out of the membrane (Figure 6E,F). There have been numerous
reports of AMPs or peptidomimetics that induce these responses [37,60,67,71,72]. The change in
membrane conduction in these cases has been assigned to a modulation of intrinsic membrane pores
via a rearrangement of the packing of the lipids according the CPP model (Figure 5).
A difficulty arises in comparing the concentration dependence of membrane disruption in
tBLM systems to the minimal inhibitory concentrations derived from in vitro bacterial growth
experiments [73]. Given that EIS measurements are limited to the antimicrobial peptides’ ability
to modulate the physical structure of the lipid membrane, the fact that these peptides have other
purported antimicrobial properties unrelated to membrane disruption must be considered [74].
Other considerations in the use of tBLMs include the ratio of tethered lipids to freely diffusing lipids
and the relative volume of the reservoir region between the substrate and the bilayer. In principle, it is
better to have as few tethered lipids, compared to freely diffusing lipids, as possible, and to have as
large a reservoir region as possible to enable the free passage of ions [75].
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Figure 6. The tethered bilayer lipid membrane (tBLM) responses presented here are actual data
obtained in the laboratory of the authors. (A) Membrane conduction and capacitance responses to
the membrane ion channel forming antibiotic α-hemolysin. (B) Phase versus frequency (Bode Plot)
before and after addition of the antibiotic α-hemolysin. The phase minima typically shift to higher
frequencies with little increase in the phase angle. (C) Membrane conduction and capacitance responses
to the human defensin peptide, LL-37, that causes membrane lysis. The responses are particularly
evident after the membrane undergoes a wash step which induces mild sheer stress at the membrane.
(D) Phase versus frequency (Bode Plot) response of LL-37. The phase minima typically shift to higher
frequencies with very large increase in the phase angle. This phase signature is evidence of the tBLM
undergoing irrevocable disruption. (E) Membrane conduction and capacitance responses to the AMP
cys-Melimine [37]. A mild increase in membrane conduction is evident at relatively high concentrations
of the AMP with a small change in membrane capacitance. The responses are partially reversed after
washing. Note that the concentration of the AMP is 10 times larger than that for the ion channel
α-hemolysin (Figure 6A). (F) Phase versus frequency (Bode Plot) response of the AMP cys-Melimine.
The phase minima typically shift to higher frequencies with only a small increase in the phase angle.
3. Antimicrobial–Lipid Membrane Interactions Investigated Using tBLMs
3.1. Testing the Lipid Specificity of AMPs
There have been numerous studies that have shown how antimicrobials have a preference for
negatively charged lipids over zwitterionic lipids [37,64,76]. The relative high number of positively
charged amino acids reported in AMPs confer this preference through electrostatic attraction. However,
there is not always a correlation between a peptide’s charge and its affinity for negatively charged
lipids. The bespoke antimicrobial peptide chimera of melittin and protamine, melimine, and its analogs
have been investigated by Australian researchers using tBLMs and their actions have been described
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according to the CPP model as mentioned above [37]. Despite the presence of multiple positively
charged amino acid residues in these peptides, there was little correlation with their interactions in
tBLMs comprised of a high percentage of negatively charged lipids. Instead, a correlation was made
according to the number and location of hydrophobic peptide residues.
Researchers in Sydney, Australia, studied a group of bespoke biphenyl peptidomimetics using
tBLMs to identify their mechanism of action. Zwitterionic and negatively charged lipids were
employed to determine how headgroup charges may modulate the electrostatic interactions of these
peptidomimetics [72]. For each synthetic peptidomimic, their capacity to disrupt tBLMs was compared
to their minimum inhibitory concentration (MIC) against bacteria and was found to not consistently
correlate. This was used as evidence that the antimicrobial mechanisms of these peptidomimetics were
not necessarily as a result of their actions on negatively charged bacterial membranes.
Other small molecular antimicrobial peptidomimics, N-naphthoyl-phenylglyoxamide-based and
N-sulfonylphenylglyoxamide-based antimicrobial peptides, were investigated to determine whether
the mechanism of action was related to their capacity to disrupt phospholipid membranes [60,67].
In each case, their membrane interactions were described using the CPP pore modulation model and
only partially correlated with the MIC observed in bacterial experiments.
In the case of the naturally occurring Kalata B1 and Kalata B2 cyclic antimicrobial and insecticidal
peptides (of which researchers from the David Craik laboratory at the University of Queensland are
recognized world leaders [77]), their specificity for membranes that contain phosphotidyl ethanolamine
(PE) lipids was confirmed using tBLMs [56]. This specificity was derived from a binding pocket within
the peptide containing both negatively and positively charged amino acid residues which specifically
targeted PE lipids and had little affinity for negatively charged lipid headgroups [78]. Electrical
impedance spectroscopy identified large changes in the membrane capacitance and membrane
conductance suggesting activity of these cyclotides was due to a surfactant-like mechanism rather
than the previously reported pore forming mechanism [79].
These results demonstrate the capacity of tBLMs in conjunction with electrical impedance
spectroscopy to elucidate the membrane disruptive properties of novel peptidomimetics and provides
valuable information regarding affinities for particular lipid compositions. Further, tBLM technology
used in this way permits a rapid characterization of peptide/membrane interactions and provides a
basis for implementing an iterative development of synthetic peptides.
3.2. Voltametric Techniques to Explore Antimicrobial Interations
As well as electrical impedance spectroscopy, other electrical techniques, such as ramped or pulsed
amperometry can be employed to identify the actions of various antimicrobial agents. The amphipathic
antimicrobial peptide trichogin GA IV (TCG) was investigated using applied potential steps at 50 mV
increments [80]. Using this technique, the researchers determined the required membrane potentials
for incorporation of the peptide. The researchers also employed cyclic voltammetry and identified that
TCG has a voltage-gated behavior similar to the fungal peptaibol peptide alamethicin.
The use of potential steps and ramped amperometry has also been employed to identify how
peptides can make use of membrane defects to incorporate into membranes. Led by Australian
researchers, Cranfield et al. (2014) showed that by rapidly increasing the potential across the tBLM,
they could induce a detectable electroporation effect. They were then able to show that defects caused
by electroporation induced an increase in the activity of the African clawed frog antimicrobial peptide
PGLa [64].
3.3. Bacterial Surface tBLM Mimics
Significant effort has gone into creating tBLMs that better mimic the actual surface of bacteria.
There have been efforts to incorporate commercially supplied lipids from E. coli sources in tBLMs
with some success [37], but these membranes do not have the lipopolysaccharide (LPS) layer that is
associated with bacterial membranes. Recently, however, Andersson et al. (2018) from the Köper group
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at Flinders University in South Australia in collaboration with researchers from the Australian Nuclear
Science and Technology Organisation (ANSTO) were able to fuse liposomes of a lipopolysaccharide
purified from E. coli onto a monolayer of tethering lipids [81]. They were then able to test their
LPS–tBLM using the antimicrobial colistin sulfate and were able to elicit a change in the membrane
structure as evidenced by neutron scattering and EIS measures.
Spencelayh et al., (2006) were able to form tBLMs that incorporated Lipid I and Lipid II, which are
precursors to the peptidoglycan layer of bacterial cell walls. They were then able to test the glycopeptide
antibiotics vancomycin and ramoplanin against these tBLM architectures. These types of antibiotics
interfere with the formation of the peptidoglycan coatings that protect Gram-positive bacteria from
lysis. Surface plasmon resonance and EIS were employed to measure changes in membrane thickness
as a result of adding these antibiotics. Significantly, purified inner E. coli membranes were used to
form these tBLMs [82].
Outer membrane protein F (OmpF) is one of the porin transmembrane proteins found in E. coli
outer membranes and is a target for antibiotics such as colicin N [83]. Stora et al. (1999) were able to
incorporate OmpF into tBLMs and demonstrate that colicin N was able to reduce overall membrane
conduction as a result [84]. The same group were later able to self-assemble tBLMs containing cysteine
mutants of the OmpF protein which itself anchors onto the gold substrate via coordination of the
cysteine thiol group [85].
4. Conclusions
Australia and New Zealand, in particular, are home to some of the world’s leading researchers
into the use of tethered bilayer lipid membranes for antimicrobial research. Australia is also the home
of the world’s only commercial supplier of tethered bilayer lipid membranes. In this work, we have
reviewed how this technology has been used to assist in identifying how antimicrobial agents interact
with lipid bilayers and, where appropriate, highlighted the works of the southern hemisphere research
groups who are the leaders in this field of research.
Author Contributions: Writing—original draft preparation, A.A, A.G., T.B., and C.C.; Writing—review and
editing, A.G., and C.C.
Funding: This research was funded by Australian Research Council (ARC) Discovery Program (DP160101664),
the ARC Research Hub for Integrated Device for End-user Analysis at Low-levels (IDEAL) (IH150100028) and the
UTS Chancellor’s Postdoctoral Research Fellowship Scheme.
Acknowledgments: We wish to acknowledge the contribution of Bruce Cornell (SDX Tethered Membranes Pty.
Ltd.) for helpful comments concerning the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389. [CrossRef] [PubMed]
2. Mueller, P.; Rudin, D.O.; Tien, H.T.; Wescott, W.C. Reconstitution of cell membrane structure in vitro and its
transformation into an excitable system. Nature 1962, 194, 979–980. [CrossRef] [PubMed]
3. Winterhalter, M. Black lipid membranes. Curr. Opin. Colloid Interface Sci. 2000, 5, 250–255. [CrossRef]
4. Cullis, P.R.; Fenske, D.B.; Hope, M.J. Chapter 1—Physical properties and functional roles of lipids in
membranes. In New Comprehensive Biochemistry; Vance, D.E., Vance, J.E., Eds.; Elsevier: Amsterdam,
The Netherlands, 1996; Volume 31, pp. 1–33.
5. Tamm, L.K.; McConnell, H.M. Supported phospholipid bilayers. Biophys. J. 1985, 47, 105–113. [CrossRef]
6. Merkel, R.; Sackmann, E.; Evans, E. Molecular friction and epitactic coupling between monolayers in
supported bilayers. J. Phys. Fr. 1989, 50, 1535–1555. [CrossRef]
7. Kuhner, M.; Tampe, R.; Sackmann, E. Lipid mono- and bilayer supported on polymer films: Composite
polymer-lipid films on solid substrates. Biophys. J. 1994, 67, 217–226. [CrossRef]
8. Thompson, N.L.; Poglitsch, C.L.; Timbs, M.M.; Pisarchick, M.L. Dynamics of antibodies on planar model
membranes. Acc. Chem. Res. 1993, 26, 567–573. [CrossRef]
Antibiotics 2019, 8, 12 10 of 13
9. Poglitsch, C.L.; Sumner, M.T.; Thompson, N.L. Binding of IgG to MoFc gamma RII purified and reconstituted
into supported planar membranes as measured by total internal reflection fluorescence microscopy.
Biochemistry 1991, 30, 6662–6671. [CrossRef]
10. Hinterdorfer, P.; Baber, G.; Tamm, L.K. Reconstitution of membrane fusion sites. A total internal reflection
fluorescence microscopy study of influenza hemagglutinin-mediated membrane fusion. J. Biol. Chem. 1994,
269, 20360–20368.
11. Salafsky, J.; Groves, J.T.; Boxer, S.G. Architecture and function of membrane proteins in planar supported
bilayers: A study with photosynthetic reaction centers. Biochemistry 1996, 35, 14773–14781. [CrossRef]
12. Wagner, M.L.; Tamm, L.K. Tethered polymer-supported planar lipid bilayers for reconstitution of integral
membrane proteins: Silane-polyethyleneglycol-lipid as a cushion and covalent linker. Biophys. J. 2000,
79, 1400–1414. [CrossRef]
13. Raguse, B.; Braach-Maksvytis, V.; Cornell, B.A.; King, L.G.; Osman, P.D.J.; Pace, R.J.; Wieczorek, L. Tethered
Lipid Bilayer Membranes: Formation and Ionic Reservoir Characterization. Langmuir 1998, 14, 648–659.
[CrossRef]
14. Elender, G.; Kühner, M.; Sackmann, E. Functionalisation of Si/SiO2 and glass surfaces with ultrathin dextran
films and deposition of lipid bilayers. Biosens. Bioelectron. 1996, 11, 565–577. [CrossRef]
15. Dietrich, C.; Tampé, R. Charge determination of membrane molecules in polymer-supported lipid layers.
Biochim. Biophys. Acta (BBA) Biomembr. 1995, 1238, 183–191. [CrossRef]
16. Baumgart, T.; Offenhäusser, A. Polysaccharide-Supported Planar Bilayer Lipid Model Membranes. Langmuir
2003, 19, 1730–1737. [CrossRef]
17. Hillebrandt, H.; Wiegand, G.; Tanaka, M.; Sackmann, E. High Electric Resistance Polymer/Lipid Composite
Films on Indium-Tin-Oxide Electrodes. Langmuir 1999, 15, 8451–8459. [CrossRef]
18. Spinke, J.; Yang, J.; Wolf, H.; Liley, M.; Ringsdorf, H.; Knoll, W. Polymer-supported bilayer on a solid
substrate. Biophys. J. 1992, 63, 1667–1671. [CrossRef]
19. Beyer, D.; Elender, G.; Knoll, W.; Kühner, M.; Maus, S.; Ringsdorf, H.; Sackmann, E. Influence of Anchor
Lipids on the Homogeneity and Mobility of Lipid Bilayers on Thin Polymer Films. Angew. Chem. Int.
Ed. Engl. 1996, 35, 1682–1685. [CrossRef]
20. Cornell, B.A.; Braach-Maksvytis, V.L.; King, L.G.; Osman, P.D.; Raguse, B.; Wieczorek, L.; Pace, R.J.
A biosensor that uses ion-channel switches. Nature 1997, 387, 580–583. [CrossRef]
21. Hausch, M.; Zentel, R.; Knoll, W. Synthesis and characterization of hydrophilic lipopolymers for the support
of lipid bilayers. Macromol. Chem. Phys. 1999, 200, 174–179. [CrossRef]
22. Vockenroth, I.K.; Ohm, C.; Robertson, J.W.F.; McGillivray, D.J.; Lösche, M.; Köper, I. Stable insulating tethered
bilayer lipid membranes. Biointerphases 2008, 3, FA68–FA73. [CrossRef] [PubMed]
23. Tun, T.N.; Jenkins, A.T.A. An electrochemical impedance study of the effect of pathogenic bacterial toxins on
tethered bilayer lipid membrane. Electrochem. Commun. 2010, 12, 1411–1415. [CrossRef]
24. Schiller, S.M.; Naumann, R.; Lovejoy, K.; Kunz, H.; Knoll, W. Archaea Analogue Thiolipids for Tethered
Bilayer Lipid Membranes on Ultrasmooth Gold Surfaces. Angew. Chem. Int. Ed. 2003, 42, 208–211. [CrossRef]
[PubMed]
25. Giess, F.; Friedrich, M.G.; Heberle, J.; Naumann, R.L.; Knoll, W. The Protein-Tethered Lipid Bilayer: A Novel
Mimic of the Biological Membrane. Biophys. J. 2004, 87, 3213–3220. [CrossRef]
26. Naumann, R.; Schiller, S.M.; Giess, F.; Grohe, B.; Hartman, K.B.; Kärcher, I.; Köper, I.; Lübben, J.; Vasilev, K.;
Knoll, W. Tethered Lipid Bilayers on Ultraflat Gold Surfaces. Langmuir 2003, 19, 5435–5443. [CrossRef]
27. Andersson, J.; Koper, I. Tethered and Polymer Supported Bilayer Lipid Membranes: Structure and Function.
Membranes 2016, 6, 30. [CrossRef]
28. Budvytyte, R.; Valincius, G.; Niaura, G.; Voiciuk, V.; Mickevicius, M.; Chapman, H.; Goh, H.Z.; Shekhar, P.;
Heinrich, F.; Shenoy, S.; et al. Structure and properties of tethered bilayer lipid membranes with unsaturated
anchor molecules. Langmuir 2013, 29, 8645–8656. [CrossRef]
29. Lin, J.; Szymanski, J.; Searson, P.C.; Hristova, K. Effect of a polymer cushion on the electrical properties and
stability of surface-supported lipid bilayers. Langmuir 2010, 26, 3544–3548. [CrossRef]
30. Budvytyte, R.; Mickevicius, M.; Vanderah, D.J.; Heinrich, F.; Valincius, G. Modification of tethered bilayers
by phospholipid exchange with vesicles. Langmuir 2013, 29, 4320–4327. [CrossRef]
31. Becucci, L.; Innocenti, M.; Bellandi, S.; Guidelli, R. Permeabilization of mercury-supported biomimetic
membranes by amphotericin B and the role of calcium ions. Electrochim. Acta 2013, 112, 719–726. [CrossRef]
Antibiotics 2019, 8, 12 11 of 13
32. Becucci, L.; Guidelli, R. Mercury-Supported Biomimetic Membranes for the Investigation of Antimicrobial
Peptides. Pharmaceuticals 2014, 7, 136. [CrossRef] [PubMed]
33. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol.
2005, 3, 238–250. [CrossRef]
34. Shai, Y. Mode of action of membrane active antimicrobial peptides. Pept. Sci. 2002, 66, 236–248. [CrossRef]
[PubMed]
35. Reddy, K.V.R.; Yedery, R.D.; Aranha, C. Antimicrobial peptides: Premises and promises. Int. J. Antimicrob. Agents
2004, 24, 536–547. [CrossRef] [PubMed]
36. Cranfield, C.G.; Berry, T.; Holt, S.A.; Hossain, K.R.; Le Brun, A.P.; Carne, S.; Al Khamici, H.; Coster, H.;
Valenzuela, S.M.; Cornell, B. Evidence of the Key Role of H3O+ in Phospholipid Membrane Morphology.
Langmuir 2016, 32, 10725–10734. [CrossRef] [PubMed]
37. Berry, T.; Dutta, D.; Chen, R.; Leong, A.; Wang, H.; Donald, W.A.; Parviz, M.; Cornell, B.; Willcox, M.;
Kumar, N.; et al. Lipid Membrane Interactions of the Cationic Antimicrobial Peptide Chimeras Melimine
and Cys-Melimine. Langmuir 2018, 34, 11586–11592. [CrossRef]
38. Mahlapuu, M.; Håkansson, J.; Ringstad, L.; Björn, C. Antimicrobial peptides: An emerging category of
therapeutic agents. Front. Cell. Infect. Microbiol. 2016, 6, 194. [CrossRef]
39. Gaspar, D.; Veiga, A.S.; Castanho, M.A. From antimicrobial to anticancer peptides. A review. Front. Microbiol.
2013, 4, 294. [CrossRef] [PubMed]
40. Wimley, W.C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model.
ACS Chem. Biol. 2010, 5, 905–917. [CrossRef] [PubMed]
41. Fjell, C.D.; Hiss, J.A.; Hancock, R.E.; Schneider, G. Designing antimicrobial peptides: Form follows function.
Nat. Rev. Drug Discov. 2011, 11, 37–51. [CrossRef] [PubMed]
42. Guilhelmelli, F.; Vilela, N.; Albuquerque, P.; Derengowski Lda, S.; Silva-Pereira, I.; Kyaw, C.M. Antibiotic
development challenges: The various mechanisms of action of antimicrobial peptides and of bacterial
resistance. Front. Microbiol. 2013, 4, 353. [CrossRef]
43. Kumar, P.; Kizhakkedathu, J.N.; Straus, S.K. Antimicrobial Peptides: Diversity, Mechanism of Action and
Strategies to Improve the Activity and Biocompatibility In Vivo. Biomolecules 2018, 8, 4. [CrossRef]
44. Giacometti, A.; Cirioni, O.; Greganti, G.; Quarta, M.; Scalise, G. In vitro activities of membrane-active
peptides against gram-positive and gram-negative aerobic bacteria. Antimicrob. Agents Chemother. 1998,
42, 3320–3324. [CrossRef]
45. Tossi, A.; Sandri, L.; Giangaspero, A. Amphipathic, α-helical antimicrobial peptides. Pept. Sci. 2000, 55, 4–30.
[CrossRef]
46. Hultmark, D.; Engström, A.; Andersson, K.; Steiner, H.; Bennich, H.; Boman, H. Insect immunity. Attacins,
a family of antibacterial proteins from Hyalophora cecropia. EMBO J. 1983, 2, 571–576. [CrossRef]
47. Ehrenstein, G.; Lecar, H. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 1977, 10, 1–34.
[CrossRef]
48. Yang, L.; Harroun, T.A.; Weiss, T.M.; Ding, L.; Huang, H.W. Barrel-stave model or toroidal model? A case
study on melittin pores. Biophys. J. 2001, 81, 1475–1485. [CrossRef]
49. Matsuzaki, K.; Murase, O.; Fujii, N.; Miyajima, K. An Antimicrobial Peptide, Magainin 2, Induced Rapid
Flip-Flop of Phospholipids Coupled with Pore Formation and Peptide Translocation. Biochemistry 1996,
35, 11361–11368. [CrossRef]
50. Hallock, K.J.; Lee, D.-K.; Ramamoorthy, A. MSI-78, an analogue of the magainin antimicrobial peptides,
disrupts lipid bilayer structure via positive curvature strain. Biophys. J. 2003, 84, 3052–3060. [CrossRef]
51. Sokolov, Y.; Mirzabekov, T.; Martin, D.W.; Lehrer, R.I.; Kagan, B.L. Membrane channel formation by
antimicrobial protegrins. Biochim. Et Biophys. Acta (BBA) Biomembr. 1999, 1420, 23–29. [CrossRef]
52. Wiedman, G.; Herman, K.; Searson, P.; Wimley, W.C.; Hristova, K. The electrical response of bilayers to
the bee venom toxin melittin: Evidence for transient bilayer permeabilization. Biochim. Biophys. Acta 2013,
1828, 1357–1364. [CrossRef]
53. Pouny, Y.; Rapaport, D.; Mor, A.; Nicolas, P.; Shai, Y. Interaction of antimicrobial dermaseptin and its
fluorescently labeled analogs with phospholipid membranes. Biochemistry 1992, 31, 12416–12423. [CrossRef]
54. Yamaguchi, S.; Huster, D.; Waring, A.; Lehrer, R.I.; Kearney, W.; Tack, B.F.; Hong, M. Orientation and
dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys. J. 2001,
81, 2203–2214. [CrossRef]
Antibiotics 2019, 8, 12 12 of 13
55. Ladokhin, A.S.; White, S.H. ‘Detergent-like’permeabilization of anionic lipid vesicles by melittin. Biochim. Et
Biophys. Acta (BBA) Biomembr. 2001, 1514, 253–260. [CrossRef]
56. Cranfield, C.G.; Henriques, S.T.; Martinac, B.; Duckworth, P.A.; Craik, D.J.; Cornell, B. Kalata B1 and Kalata
B2 Have a Surfactant-Like Activity in Phosphatidylethanolomine Containing Lipid Membranes. Langmuir
2017, 33, 6630–6637. [CrossRef]
57. Boge, L.; Bysell, H.; Ringstad, L.; Wennman, D.; Umerska, A.; Cassisa, V.; Eriksson, J.; Joly-Guillou, M.L.;
Edwards, K.; Andersson, M. Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase
Behavior and Antimicrobial Effect. Langmuir 2016, 32, 4217–4228. [CrossRef]
58. Daghastanli, K.R.; Ferreira, R.B.; Thedei, G., Jr.; Maggio, B.; Ciancaglini, P. Lipid composition-dependent
incorporation of multiple membrane proteins into liposomes. Colloids Surf. B Biointerfaces 2004, 36, 127–137.
[CrossRef]
59. Gontsarik, M.; Buhmann, M.T.; Yaghmur, A.; Ren, Q.; Maniura-Weber, K.; Salentinig, S. Antimicrobial
Peptide-Driven Colloidal Transformations in Liquid-Crystalline Nanocarriers. J. Phys. Chem. Lett. 2016,
7, 3482–3486. [CrossRef]
60. Yu, T.T.; Nizalapur, S.; Ho, K.K.; Yee, E.; Berry, T.; Cranfield, C.G.; Willcox, M.; Black, D.S.; Kumar, N. Design,
Synthesis and Biological Evaluation of N-Sulfonylphenyl glyoxamide-Based Antimicrobial Peptide Mimics
as Novel Antimicrobial Agents. ChemistrySelect 2017, 2, 3452–3461. [CrossRef]
61. Israelachvili, J.N.; Marcˇelja, S.; Horn, R.G. Physical principles of membrane organization. Q. Rev. Biophys.
1980, 13, 121–200. [CrossRef]
62. Israelachvili, J.N.; Mitchell, D.J.; Ninham, B.W. Theory of self-assembly of hydrocarbon amphiphiles into
micelles and bilayers. J. Chem. Socfaraday Trans. 2 1976, 72, 1525–1568. [CrossRef]
63. Tilley, S.J.; Saibil, H.R. The mechanism of pore formation by bacterial toxins. Curr. Opin. Struct. Biol. 2006,
16, 230–236. [CrossRef]
64. Cranfield, C.G.; Cornell, B.A.; Grage, S.L.; Duckworth, P.; Carne, S.; Ulrich, A.S.; Martinac, B. Transient
potential gradients and impedance measures of tethered bilayer lipid membranes: Pore-forming peptide
insertion and the effect of electroporation. Biophys. J. 2014, 106, 182–189. [CrossRef]
65. McGillivray, D.J.; Valincius, G.; Heinrich, F.; Robertson, J.W.; Vanderah, D.J.; Febo-Ayala, W.; Ignatjev, I.;
Losche, M.; Kasianowicz, J.J. Structure of functional Staphylococcus aureus alpha-hemolysin channels in
tethered bilayer lipid membranes. Biophys J 2009, 96, 1547–1553. [CrossRef]
66. Turner, J.; Cho, Y.; Dinh, N.-N.; Waring, A.J.; Lehrer, R.I. Activities of LL-37, a cathelin-associated
antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 1998, 42, 2206–2214. [CrossRef]
67. Nizalapur, S.; Ho, K.K.; Kimyon, Ö.; Yee, E.; Berry, T.; Manefield, M.; Cranfield, C.G.; Willcox, M.; Black, D.S.;
Kumar, N. Synthesis and biological evaluation of N-naphthoyl-phenylglyoxamide-based small molecular
antimicrobial peptide mimics as novel antimicrobial agents and biofilm inhibitors. Org. Biomol. Chem. 2016,
14, 3623–3637. [CrossRef]
68. Neville, F.; Gidalevitz, D.; Kale, G.; Nelson, A. Electrochemical screening of anti-microbial peptide LL-37
interaction with phospholipids. Bioelectrochemistry 2007, 70, 205–213. [CrossRef]
69. Neville, F.; Cahuzac, M.; Nelson, A.; Gidalevitz, D. The interaction of antimicrobial peptide LL-37 with
artificial biomembranes: Epifluorescence and impedance spectroscopy approach. J. Phys. Condens. Matter
2004, 16, S2413–S2420. [CrossRef]
70. Bechinger, B.; Lohner, K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides.
Biochim. Biophys. Acta 2006, 1758, 1529–1539. [CrossRef]
71. Nizalapur, S.; Kimyon, O.; Yee, E.; Ho, K.; Berry, T.; Manefield, M.; Cranfield, C.G.; Willcox, M.; Black, D.S.;
Kumar, N. Amphipathic guanidine-embedded glyoxamide-based peptidomimetics as novel antibacterial
agents and biofilm disruptors. Org. Biomol. Chem. 2017, 15, 2033–2051. [CrossRef]
72. Kuppusamy, R.; Yasir, M.; Berry, T.; Cranfield, C.G.; Nizalapur, S.; Yee, E.; Kimyon, O.; Taunk, A.; Ho, K.K.;
Cornell, B. Design and synthesis of short amphiphilic cationic peptidomimetics based on biphenyl backbone
as antibacterial agents. Eur. J. Med. Chem. 2018, 143, 1702–1722. [CrossRef] [PubMed]
73. Hovakeemian, S.G.; Liu, R.; Gellman, S.H.; Heerklotz, H. Correlating antimicrobial activity and model
membrane leakage induced by nylon-3 polymers and detergents. Soft Matter 2015, 11, 6840–6851. [CrossRef]
[PubMed]
74. Epand, R.M.; Vogel, H.J. Diversity of antimicrobial peptides and their mechanisms of action.
Biochim. Biophys. Acta 1999, 1462, 11–28. [CrossRef]
Antibiotics 2019, 8, 12 13 of 13
75. Krishna, G.; Schulte, J.; Cornell, B.A.; Pace, R.J.; Osman, P.D. Tethered bilayer membranes containing ionic
reservoirs: Selectivity and conductance. Langmuir 2003, 19, 2294–2305. [CrossRef]
76. Niu, L.; Wohland, T.; Knoll, W.; Köper, I. Interaction of a synthetic antimicrobial peptide with a model bilayer
platform mimicking bacterial membranes. Biointerphases 2017, 12, 04E404. [CrossRef] [PubMed]
77. Poth, A.G.; Colgrave, M.L.; Lyons, R.E.; Daly, N.L.; Craik, D.J. Discovery of an unusual biosynthetic origin
for circular proteins in legumes. Proc. Natl. Acad. Sci. USA 2011, 108, 10127–10132. [CrossRef] [PubMed]
78. Henriques, S.T.; Huang, Y.-H.; Rosengren, K.J.; Franquelim, H.G.; Carvalho, F.A.; Johnson, A.; Sonza, S.;
Tachedjian, G.; Castanho, M.A.; Daly, N.L. Decoding the membrane activity of the cyclotide kalata B1:
The importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and
anti-HIV activities. J. Biol. Chem. 2011, 286, 24231–24241. [CrossRef] [PubMed]
79. Wang, C.K.; Wacklin, H.P.; Craik, D.J. Cyclotides insert into lipid bilayers to form membrane pores
and destabilize the membrane through hydrophobic and phosphoethanolamine-specific interactions.
J. Biol. Chem. 2012, 287, 43884–43898. [CrossRef]
80. Becucci, L.; Maran, F.; Guidelli, R. Probing membrane permeabilization by the antibiotic lipopeptaibol
trichogin GA IV in a tethered bilayer lipid membrane. Biochim. Biophys. Acta (BBA) Biomembr. 2012,
1818, 1656–1662. [CrossRef] [PubMed]
81. Andersson, J.; Fuller, M.A.; Wood, K.; Holt, S.A.; Köper, I. A tethered bilayer lipid membrane that mimics
microbial membranes. Phys. Chem. Chem. Phys. 2018, 20, 12958–12969. [CrossRef]
82. Spencelayh, M.J.; Cheng, Y.; Bushby, R.J.; Bugg, T.D.; Li, J.j.; Henderson, P.J.; O’Reilly, J.; Evans, S.D. Antibiotic
action and peptidoglycan formation on tethered lipid bilayer membranes. Angew. Chem. 2006, 118, 2165–2170.
[CrossRef]
83. Zakharov, S.D.; Eroukova, V.Y.; Rokitskaya, T.I.; Zhalnina, M.V.; Sharma, O.; Loll, P.J.; Zgurskaya, H.I.;
Antonenko, Y.N.; Cramer, W.A. Colicin occlusion of OmpF and TolC channels: Outer membrane translocons
for colicin import. Biophys. J. 2004, 87, 3901–3911. [CrossRef] [PubMed]
84. Stora, T.; Lakey, J.H.; Vogel, H. Ion-channel gating in transmembrane receptor proteins: Functional activity
in tethered lipid membranes. Angew. Chem. Int. Ed. 1999, 38, 389–392. [CrossRef]
85. Terrettaz, S.; Ulrich, W.P.; Vogel, H.; Hong, Q.; Dover, L.G.; Lakey, J.H. Stable self-assembly of a protein
engineering scaffold on gold surfaces. Protein Sci. 2002, 11, 1917–1925. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
